Veryan gains CE mark for leg artery stent; Affordable Care Act uncertainty slows device M&A;

 @FierceMedDev: Cyberonics, a maker of neuromodulation devices, had a great Fy2013 Q2. Story | Follow @FierceMedDev

 @MarkHFierce: Thermo Fisher unveiled a new manufacturing facility in China. Item | Follow @MarkHFierce

 @DamianFierce: As advocates fight to repeal the device tax, we take a detailed look at how the 2.3% charge would work. Special Report | Follow @DamianFierce

> Cambridge Heart ($CAMH) reduced its losses during the third quarter, even as sales declined, which was enough to drive a significant boost in share price. Story

> Veryan won a CE mark for its new BioMimics 3D stent, which is designed to treat superficial femoral and proximal popliteal leg arteries. Release

> Medical device M&A deals have generally remained steady over the last three-plus years, according to a new report, though uncertainty over the Affordable Care Act's implementation slowed activity in the 2012 third quarter. Story

> One year after Australia's Senate called for medical device registries to help reduce the amount of faulty products, plans to launch the effort remain vague and in limbo. Item

> Larsen & Toubro, an engineering and construction company based in India, is selling its medical equipment business to Skanray Healthcare, an Indian company that sells diagnostic imaging products and medical devices used for primary healthcare. Story

> The global market for disposable medical supplies should reach nearly $200 billion by 2016, according to a new industry report. Item

> Insulet ($PODD), a maker of insulin pumps, made the list of Deloitte's "Technology Fast 500," a ranking of the fastest growing companies in North America in a variety of sectors. Release

Biotech News

 @FierceBiotech: Novartis grabs EU committee support for first meningitis B vaccine. Article | Follow @FierceBiotech

 @JohnCFierce: Somehow doubt that Biocon really wanted an option deal for IN-105, its oral insulin program. More | Follow @JohnCFierce

 @RyanMFierce: Dynavax stock in pre-market meltdown mode after adcomm on hep B vax didn't back safety. More | Follow @RyanMFierce

> Bristol-Myers Squibb grabs option to Biocon's oral insulin amid diabetes growth. News

> Biotech outfit Geron nears spinoff of stem cell business. Story

Pharma News

@FiercePharma: Whistleblower lawsuit on Pfizer's Lipitor dismissed. Story | Follow @FiercePharma

> Novartis vaccines get booster shot with EMA nod for Bexsero. Story

> GlaxoSmithKline to pay out $90M more for Avandia claims. Article

> Sanofi gets EMA yes for diabetes drug Lyxumia, Zaltrap cancer med. News